Anti-PD-(L) 1 therapies yield a disappointing response rate of 15% across soft-tissue
sarcomas, even if some subtypes benefit more than others. The proportions of TAMs and …

Simple Summary Soft tissue sarcomas represent a large heterogeneous group of malignant
neoplasms that are characterized by a poor disease outcome and being poorly studied …

Lung adenocarcinoma (LUAD) is a malignant tumor with high lethality, and the aim of this
study was to identify promising biomarkers for LUAD. Using the TCGA-LUAD dataset as a …

Soft tissue sarcomas (STSs) are a family of rare malignant tumors encompassing more than
80 histologies. Current therapies for metastatic STS, a condition that affects roughly half of …

Immunotherapy in Sarcoma - Surgical Oncology Clinics Skip to Main Content Skip to Main
Menu Advertisement Surgical Oncology Clinics Log in Register Log in Subscribe Claim Cart …

Background Soft-tissue sarcomas (STSs) are heterogeneous and aggressive tumors, with
high metastatic risk. The immunologic constant of rejection (ICR) 20-gene signature is a …

Simple Summary Soft Tissue Sarcomas are a rare and heterogeneous group of tumors,
which have a characteristic complexity, leading to a difficult diagnosis and a lack of …

Background Gliomas, a prevalent form of primary brain tumors, are linked with a high
mortality rate and unfavorable prognoses. Disulfidptosis, an innovative form of programmed …

Objective This study aimed at constructing a network of competing endogenous RNA
(ceRNA) in the synovial tissues of rheumatoid arthritis (RA). It seeks to discern potential …

Sarcomas are a heterogeneous group of over 150 mesenchymal neoplasms of bone and
soft tissue. Clinical prognosis remains poor in the metastatic and refractory setting, despite …